RRM2 and malignant colon neoplasm: Therefore, the increase in RRM2 K283cr can enhance the cytotoxic tolerance of colon cancer cells to cisplatin treatment after p53 knockout, and SIRT7 was found to be its de-crotonylation enzyme.